|
Match
|
Document |
Document Title |
|
|
7390519 |
Probiotic Lactobacillus salivarius strains
A Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants thereof are useful in the prophylaxis and/or treatment of inflammatory activity especially...
|
|
|
7384628 |
Lactic acid bacteria and its use in direct-fed microbials
A composition comprising lactic acid bacteria that are selected from at least one of Lactococcus lactis, Lactobacillus lactis , and Lactobacillus brevis . The composition is suitable for...
|
|
|
7381406 |
Probiotic lactobacillus strains for pets
The present invention provides novel strains of probiotics for use in the gastrointestinal tract of a pet. The probiotics of the present invention are capable of fermenting starch to produce lactic...
|
|
|
7374924 |
Use of selected lactic acid bacteria for reducing infantile colic
The invention herein provides certain strains of lactic acid bacteria selected for their capability of promoting production of IL-10 and consequently proliferation of CD4+CD25+ TR cells, for...
|
|
|
7354757 |
Lactobacillus brevis strain
Lactobacillus strains that have a genetic Profile I based on Apa I, Not I, and Xba I digests are provided. Preferably, the strains decrease level of at least one of coliforms and E. coli within...
|
|
|
7351572 |
Microorganism strain GM-090 of Lactobacillus fermentum and its use for stimulating IFN-γ secretion and/or treating allergy
The present invention provides an isolated microorganism strain, Lactobacillus fermentum GM-090, which is found to be effective in stimulating IFN-γ secretion and/or treating allergy. The use of...
|
|
|
7344867 |
Selection and use of lactic acid bacteria for reducing inflammation in mammals
Strains of lactic acid bacteria selected for their capability of reducing inflammation, such as intestinal bowel disease, a method of selecting such strains, and products containing such strains.
|
|
|
7323166 |
Lactic acid bacteria cultures that inhibit food-borne pathogens
The present invention provides methods and compositions for preventing or inhibiting human food-borne pathogens in animals, and methods for increasing feed efficiency in animals by administering to...
|
|
|
RE40023 |
Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
A pharmaceutical composition containing several different bacteria including Streptococcus thermophilus, Lactobacilli and Bifidobacteria is disclosed. The bacteria are present in the composition at...
|
|
|
7318920 |
Low water activity nutritional product having beneficial microbial and high oil content
The present invention relates to a composition for the oral administration of beneficial microorganisms in a discrete dosage form, comprising about 10% to about 50% by weight of a starch component,...
|
|
|
7312067 |
Lactic acid producing bacteria for use as probiotic organisms in the human vagina
The present invention discloses novel isolated strains of lactic acid producing bacteria of the genera Lactobacillus and Pediococcus , and a method for isolation of such bacterial strains,...
|
|
|
7303745 |
Method for preventing or treating the development of respiratory allergies
The present invention is directed to a novel method for preventing or treating the development of respiratory allergies. The method comprises prenatal and/or postnatal administration of a...
|
|
|
7294337 |
Use of Lactobacillus farciminis for the prevention or treatment of digestive pathologies
The invention relates to the use of lactic bacteria of the species Lactobacillus farciminis for the treatment or prevention of a pathology of the digestive tube, especially an acute or chronic...
|
|
|
7291328 |
Method to enhance fat content in the milk of a diary cow
The disclosure describes a method of administering an amount of a lactic acid producing bacterium such as Lactobacillus acidophilus alone or in combination with a lactate utilizing bacterium such...
|
|
|
7291327 |
Compositions and methods for inhibiting pathogenic growth
The invention includes methods and compositions for treating an animal to inhibit the incidence and growth of E. coli O157:H7 and other pathogenic bacteria. The treatment method comprises...
|
|
|
7291326 |
Compositions and methods for reducing the pathogen content of meat and meat products
Compositions and methods useful for reducing or eliminating the presence of pathogens in meat and meat products are disclosed. Administration of one or more lactic acid producing microorganisms to...
|
|
|
7288245 |
Composition having immunoregulating activities
The invention provides a composition comprising novel lactic acid bacteria having immunoregulating activities. Specifically, the invention provides food, drinks or medicaments containing novel...
|
|
|
RE39892 |
Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections and related method
Use of an association of lactobacilli for preparation of a pharmaceutical composition for treatment of vaginosis and vaginitis. Said bacteria association comprises the Lactobacillus brevis and...
|
|
|
7282354 |
Method for producing fermented milk product
There is provided a fermented milk product that contains lactic acid bacteria capable of producing a large amount of lactotripeptide and a large amount of active ingredient having hypotensive...
|
|
|
RE39876 |
Kit with enteral dietary composition consisting of Streptococcus thermophilus, Bifidobacterium infantis and Bifidobacterium longum
Enteral compositions containing Streptococcus thermophilus, Bifidobacterium infantis and Bifidobacterium longum, each at a concentration equal to or greater than 1×10 11 CFU per gram, are useful...
|
|
|
7270994 |
Lactobacillus casei Bd-II stain and used to reduce blood cholesterol
The invention disclosed a kind of lactobacillus casei Bd-II, the accession number of the deposit of which is CGMCC NO.0849, and also disclosed a use of it for reducing blood lipid level. Further,...
|
|
|
7244425 |
Acid- and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
Disclosed are acid- and bile salt-resistant Lactobacillus isolates having the ability to lower cholesterol. The present Lactobacillus isolates or their sub-cultured offspring or mutants derived...
|
|
|
7244424 |
Strain of micro-organism Lactobacillus fermentum ME-3 as novel anti-microbiol and anti-oxidative probiotic
The strain of micro-organism Lactobacillus fermentum ME-3 is a novel anti-microbial and anti-oxidative probiotic. It has a high anti-microbial effect on Escherichia coli, Shigella sonnei,...
|
|
|
7241441 |
Microorganism Pediococcus pentosaceus EROM101, having immune enhancement, anticancer and antimicrobial activities
The present invention relates to a novel Pediococcus genus microorganism and more particularly, Pediococcus pentosaceus EROM101 (KCCM-10517) originated from human intestines having immune...
|
|
|
7235395 |
Lactic acid bacteria as agents for treating and preventing allergy
The present invention pertains to novel strains of lactic acid bacteria capable of reducing an individual's tendency to react allergic against a variety of different allergens. In particular, the...
|
|
|
7229616 |
Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis
The present invention relates to the use of a supernatant of lactic acid bacteria or of Bifidobacteria capable of preventing colonization of intestinal cells by Giardia intestinalis , for the...
|
|
|
7220418 |
Delivery of trefoil peptides
The present invention relates to a microorganism, preferably a bacterial strain, preferably a non-pathogenic strain, preferably a non-invasive strain, preferably a food grade strain, preferably a...
|
|
|
7220409 |
Stabilization of immunoglobulins at low pH
The present invention provides a method of stabilizing immunoglobulins in a solution having a pH below 4 by adding cereals or hydrolysed cereal products in an amount sufficient to prevent...
|
|
|
7217414 |
Methods of preventing peritonitis by administering lactic acid bacterium
The present invention relates to the use of lactic acid bacteria capable of adhering to the mucosa of the intestine and especially colonizing it for the prevention of peritonitis. In particular,...
|
|
|
7214370 |
Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
Probiotic compositions derived from Lactobacillus casei ATCC number PTA 3945 are disclosed. More specifically, probiotic compositions containing prebiotic compositions including edible oils are...
|
|
|
RE39585 |
Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
This invention provides materials and procedures for the delivery of selected strains of bacteria and/or oxalate-degrading enzymes to the intestinal tracts of persons who are at increased risk for...
|
|
|
7202219 |
Use of D-tagatose as a prebiotic food component
Oral intake of D-tagatose in a prebiotic food induces production of butyrate and stimulates the growth of beneficial bacteria in the human colon. Therefore it is believed to be useful in food or...
|
|
|
7195906 |
Bifidobacterium in the treatment of inflammatory disease
A strain of Bifidobacterium isolated from resected and washed human gastrointestinal tract is significantly immunomodulatory following oral consumption in humans. The strain is useful in the...
|
|
|
7192581 |
Lactobacillus reuteri useful as probiotics
The present invention relates to a Lactobacillus reuteri variant from animal sources that inhibits rotavirus infection and other pathogenic microorganisms, as well as being tolerant of gastric...
|
|
|
7189390 |
Probiotics for pet food applications
The present invention relates to novel lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood...
|
|
|
7186545 |
Probiotic strains from Lactobacillus salivarius and antimicrobial agents obtained therefrom
A strain of Lactobacillus salivarius isolated from resected and washed human gastrointestinal tract inhibits a broad range of Gram positive and Gram negative microorganisms and secretes a product...
|
|
|
7183108 |
Selection and uses of lactic acid bacteria strains modulating non-specific immunity
The invention concerns lactic acid bacteria strains capable of regulating the production of NO and inflammatory cytokines by enterocytes, depending on the inflammatory condition of said...
|
|
|
7182943 |
Method and system for modulation of microbial cell characteristics
A method and a system is disclosed for the modulation of various characteristics of probiotic cells and for the production of probiotics having altered characteristics. Such altered characteristics...
|
|
|
7172756 |
Methods of promoting tolerogenic immune responses and compositions therefor
Methods and compositions for promoting tolerogenic immune responses or treating immune responses to food antigens comprise Lactobacillus GG. Oral administration of Lactobacillus GG to patients...
|
|
|
7169383 |
Attaching substances to micro-organisms
The invention relates to surface display of proteins on micro-organisms via the targeting and anchoring of heterologous proteins to the outer surface of cells such as yeast, fungi, mammalian and...
|
|
|
7153502 |
Food or drink product with a disinfection property of Helicobacter pylori
A food or drink product with a disinfection property of Helicobacter pylori and/or a protection property against infection with H. pylori , comprising as the effective ingredient Lactobacillus...
|
|
|
7150986 |
Lactic acid bacteria-containing probiotics products
The present invention provides a probiotics product comprising, as an effective component, lactic acid bacteria belonging to Lactobacillus salivarius possessing high adhesiveness to mucous...
|
|
|
7147847 |
Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
Disclosed is the use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction, and pharmaceutical or dietetic compositions containing such bacteria....
|
|
|
7138113 |
Glycoprotein matrix compositions and methods related thereto
A composition is provided that includes a biologically active compound bound by a glycoprotein matrix. A method is also provided for the manufacture of a composition of the invention. The...
|
|
|
7132102 |
Bacteriocins and novel bacterial strains
Novel bacteriocins and/or the novel lactic acid-producing strains are used for at least reducing the levels of colonization by at least one target bacteria in animals, especially poultry.
|
|
|
7125708 |
Composition comprising a Lactobacillus pentosus strain and uses thereof
A novel probiotic strain termed Lactobacillus pentosus NCIMB 41114 is capable of preventing growth of pathogenic microorganisms in the GI tract. In particular, this bacterium inhibits Candida ...
|
|
|
7112323 |
Intracellular proteinacious antimicrobial agents from lactic acid bacteria derived from fermented food samples
The present invention is directed bacterial isolates that produce proteinacious antimicrobial agents effective against a variety of food borne pathogens. The invention includes the bacteria,...
|
|
|
7112322 |
Probiotics in primary prevention of atopic diseases
The present invention is in the field of prophylaxis of allergies, and relates specifically to primary prevention of atopic diseases by administering probiotic bacteria, beneficial microbes of the...
|
|
|
7105336 |
Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori , and products derived from these...
|
|
|
7097831 |
α-Amylase-resistant starch for producing foodstuff and medicaments
The invention relates to foodstuff and animal feed which contain resistant starch on the basis of water-insoluble linear α-1,4-D-glucans. The invention also related to the utilization of resistant...
|